Chang Ming
Ironwood Pharmaceuticals (United States)(US)Manor Hospital(GB)
Publications by Year
Research Areas
Legal and Regulatory Analysis, Linguistic, Cultural, and Literary Studies, Military Technology and Strategies, BRCA gene mutations in cancer, Dialysis and Renal Disease Management
Most-Cited Works
- → Projections of cancer incidence and cancer‐related deaths in Germany by 2020 and 2030(2016)268 cited
- Chorea-ballismus with nonketotic hyperglycemia in primary diabetes mellitus.(1996)
- → Machine learning techniques for personalized breast cancer risk prediction: comparison with the BCRAT and BOADICEA models(2019)126 cited
- → Efficacy and Safety of Abelmoschus manihot for Primary Glomerular Disease: A Prospective, Multicenter Randomized Controlled Clinical Trial(2014)125 cited
- → Predictive factors and clinical biomarkers for treatment in patients with chronic pain caused by osteoarthritis with a central sensitisation component(2015)68 cited
- → Gene and mutation independent therapy via CRISPR-Cas9 mediated cellular reprogramming in rod photoreceptors(2017)63 cited
- → Machine learning-based lifetime breast cancer risk reclassification compared with the BOADICEA model: impact on screening recommendations